nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Cyclizine—SULT1E1—coronary artery disease	0.00624	0.365	CrCbGaD
Mepenzolate—Diphenoxylate—OPRD1—coronary artery disease	0.00296	0.173	CrCbGaD
Mepenzolate—Loperamide—POMC—coronary artery disease	0.00218	0.127	CrCbGaD
Mepenzolate—Tachycardia—Niacin—coronary artery disease	0.00147	0.00244	CcSEcCtD
Mepenzolate—Dry mouth—Trandolapril—coronary artery disease	0.00147	0.00244	CcSEcCtD
Mepenzolate—Dry mouth—Enalapril—coronary artery disease	0.00147	0.00243	CcSEcCtD
Mepenzolate—Vomiting—Ticagrelor—coronary artery disease	0.00146	0.00243	CcSEcCtD
Mepenzolate—Feeling abnormal—Clopidogrel—coronary artery disease	0.00146	0.00242	CcSEcCtD
Mepenzolate—Vision blurred—Losartan—coronary artery disease	0.00145	0.0024	CcSEcCtD
Mepenzolate—Palpitations—Perindopril—coronary artery disease	0.00145	0.0024	CcSEcCtD
Mepenzolate—Confusional state—Enalapril—coronary artery disease	0.00145	0.0024	CcSEcCtD
Mepenzolate—Feeling abnormal—Lovastatin—coronary artery disease	0.00145	0.0024	CcSEcCtD
Mepenzolate—Dry mouth—Telmisartan—coronary artery disease	0.00145	0.0024	CcSEcCtD
Mepenzolate—Headache—Ticagrelor—coronary artery disease	0.00144	0.00239	CcSEcCtD
Mepenzolate—Constipation—Eplerenone—coronary artery disease	0.00144	0.00239	CcSEcCtD
Mepenzolate—Anaphylactic shock—Enalapril—coronary artery disease	0.00144	0.00238	CcSEcCtD
Mepenzolate—Urticaria—Fenofibrate—coronary artery disease	0.00143	0.00237	CcSEcCtD
Mepenzolate—Feeling abnormal—Ezetimibe—coronary artery disease	0.00142	0.00235	CcSEcCtD
Mepenzolate—Anaphylactic shock—Telmisartan—coronary artery disease	0.00142	0.00235	CcSEcCtD
Mepenzolate—Tachycardia—Trandolapril—coronary artery disease	0.00141	0.00233	CcSEcCtD
Mepenzolate—Dry mouth—Captopril—coronary artery disease	0.00141	0.00233	CcSEcCtD
Mepenzolate—Constipation—Simvastatin—coronary artery disease	0.0014	0.00233	CcSEcCtD
Mepenzolate—Urticaria—Clopidogrel—coronary artery disease	0.0014	0.00233	CcSEcCtD
Mepenzolate—Insomnia—Valsartan—coronary artery disease	0.0014	0.00233	CcSEcCtD
Mepenzolate—Tachycardia—Enalapril—coronary artery disease	0.0014	0.00233	CcSEcCtD
Mepenzolate—Nausea—Gemfibrozil—coronary artery disease	0.0014	0.00232	CcSEcCtD
Mepenzolate—Insomnia—Olmesartan—coronary artery disease	0.0014	0.00232	CcSEcCtD
Mepenzolate—Urticaria—Lovastatin—coronary artery disease	0.0014	0.00231	CcSEcCtD
Mepenzolate—Feeling abnormal—Eplerenone—coronary artery disease	0.00139	0.0023	CcSEcCtD
Mepenzolate—Confusional state—Captopril—coronary artery disease	0.00139	0.0023	CcSEcCtD
Mepenzolate—Tachycardia—Telmisartan—coronary artery disease	0.00138	0.00229	CcSEcCtD
Mepenzolate—Somnolence—Valsartan—coronary artery disease	0.00138	0.00229	CcSEcCtD
Mepenzolate—Anaphylactic shock—Captopril—coronary artery disease	0.00138	0.00229	CcSEcCtD
Mepenzolate—Dizziness—Rosuvastatin—coronary artery disease	0.00137	0.00227	CcSEcCtD
Mepenzolate—Urticaria—Ezetimibe—coronary artery disease	0.00137	0.00227	CcSEcCtD
Mepenzolate—Nausea—Ticagrelor—coronary artery disease	0.00137	0.00227	CcSEcCtD
Mepenzolate—Dry mouth—Perindopril—coronary artery disease	0.00136	0.00226	CcSEcCtD
Mepenzolate—Insomnia—Niacin—coronary artery disease	0.00136	0.00226	CcSEcCtD
Mepenzolate—Palpitations—Losartan—coronary artery disease	0.00136	0.00225	CcSEcCtD
Mepenzolate—Feeling abnormal—Simvastatin—coronary artery disease	0.00135	0.00225	CcSEcCtD
Mepenzolate—Confusional state—Perindopril—coronary artery disease	0.00135	0.00224	CcSEcCtD
Mepenzolate—Tachycardia—Captopril—coronary artery disease	0.00134	0.00223	CcSEcCtD
Mepenzolate—Insomnia—Pravastatin—coronary artery disease	0.00134	0.00223	CcSEcCtD
Mepenzolate—Somnolence—Niacin—coronary artery disease	0.00134	0.00222	CcSEcCtD
Mepenzolate—Anaphylactic shock—Perindopril—coronary artery disease	0.00134	0.00222	CcSEcCtD
Mepenzolate—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00133	0.00221	CcSEcCtD
Mepenzolate—Dry mouth—Furosemide—coronary artery disease	0.00133	0.0022	CcSEcCtD
Mepenzolate—Constipation—Valsartan—coronary artery disease	0.00133	0.0022	CcSEcCtD
Mepenzolate—Hypersensitivity—Fenofibrate—coronary artery disease	0.00132	0.0022	CcSEcCtD
Mepenzolate—Constipation—Olmesartan—coronary artery disease	0.00132	0.00219	CcSEcCtD
Mepenzolate—Confusional state—Furosemide—coronary artery disease	0.00131	0.00217	CcSEcCtD
Mepenzolate—Tachycardia—Perindopril—coronary artery disease	0.00131	0.00217	CcSEcCtD
Mepenzolate—Urticaria—Simvastatin—coronary artery disease	0.0013	0.00216	CcSEcCtD
Mepenzolate—Insomnia—Trandolapril—coronary artery disease	0.0013	0.00216	CcSEcCtD
Mepenzolate—Hypersensitivity—Clopidogrel—coronary artery disease	0.0013	0.00216	CcSEcCtD
Mepenzolate—Anaphylactic shock—Furosemide—coronary artery disease	0.0013	0.00216	CcSEcCtD
Mepenzolate—Insomnia—Enalapril—coronary artery disease	0.0013	0.00215	CcSEcCtD
Mepenzolate—Headache—Rosuvastatin—coronary artery disease	0.0013	0.00215	CcSEcCtD
Mepenzolate—Hypersensitivity—Lovastatin—coronary artery disease	0.00129	0.00215	CcSEcCtD
Mepenzolate—Tension—Ramipril—coronary artery disease	0.00129	0.00215	CcSEcCtD
Mepenzolate—Asthenia—Fenofibrate—coronary artery disease	0.00129	0.00214	CcSEcCtD
Mepenzolate—Dextropropoxyphene—OPRD1—coronary artery disease	0.00129	0.0753	CrCbGaD
Mepenzolate—Somnolence—Trandolapril—coronary artery disease	0.00128	0.00213	CcSEcCtD
Mepenzolate—Insomnia—Telmisartan—coronary artery disease	0.00128	0.00213	CcSEcCtD
Mepenzolate—Nervousness—Ramipril—coronary artery disease	0.00128	0.00212	CcSEcCtD
Mepenzolate—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00128	0.00212	CcSEcCtD
Mepenzolate—Dry mouth—Losartan—coronary artery disease	0.00128	0.00212	CcSEcCtD
Mepenzolate—Somnolence—Enalapril—coronary artery disease	0.00128	0.00212	CcSEcCtD
Mepenzolate—Fentanyl—OPRD1—coronary artery disease	0.00127	0.0745	CrCbGaD
Mepenzolate—Feeling abnormal—Olmesartan—coronary artery disease	0.00127	0.00211	CcSEcCtD
Mepenzolate—Constipation—Pravastatin—coronary artery disease	0.00127	0.00211	CcSEcCtD
Mepenzolate—Hypersensitivity—Ezetimibe—coronary artery disease	0.00127	0.0021	CcSEcCtD
Mepenzolate—Asthenia—Clopidogrel—coronary artery disease	0.00127	0.0021	CcSEcCtD
Mepenzolate—Confusional state—Losartan—coronary artery disease	0.00126	0.0021	CcSEcCtD
Mepenzolate—Tension—Timolol—coronary artery disease	0.00126	0.0021	CcSEcCtD
Mepenzolate—Asthenia—Lovastatin—coronary artery disease	0.00126	0.00209	CcSEcCtD
Mepenzolate—Somnolence—Telmisartan—coronary artery disease	0.00126	0.00209	CcSEcCtD
Mepenzolate—Anaphylactic shock—Losartan—coronary artery disease	0.00125	0.00208	CcSEcCtD
Mepenzolate—Nervousness—Timolol—coronary artery disease	0.00125	0.00208	CcSEcCtD
Mepenzolate—Insomnia—Captopril—coronary artery disease	0.00125	0.00207	CcSEcCtD
Mepenzolate—Asthenia—Ezetimibe—coronary artery disease	0.00124	0.00205	CcSEcCtD
Mepenzolate—Constipation—Trandolapril—coronary artery disease	0.00123	0.00205	CcSEcCtD
Mepenzolate—Urticaria—Valsartan—coronary artery disease	0.00123	0.00204	CcSEcCtD
Mepenzolate—Nausea—Rosuvastatin—coronary artery disease	0.00123	0.00204	CcSEcCtD
Mepenzolate—Constipation—Enalapril—coronary artery disease	0.00123	0.00204	CcSEcCtD
Mepenzolate—Loperamide—OPRD1—coronary artery disease	0.00123	0.0718	CrCbGaD
Mepenzolate—Urticaria—Olmesartan—coronary artery disease	0.00123	0.00203	CcSEcCtD
Mepenzolate—Somnolence—Captopril—coronary artery disease	0.00122	0.00203	CcSEcCtD
Mepenzolate—Tachycardia—Losartan—coronary artery disease	0.00122	0.00203	CcSEcCtD
Mepenzolate—Feeling abnormal—Pravastatin—coronary artery disease	0.00122	0.00203	CcSEcCtD
Mepenzolate—Vision blurred—Timolol—coronary artery disease	0.00121	0.00201	CcSEcCtD
Mepenzolate—Constipation—Telmisartan—coronary artery disease	0.00121	0.00201	CcSEcCtD
Mepenzolate—Hypersensitivity—Simvastatin—coronary artery disease	0.00121	0.00201	CcSEcCtD
Mepenzolate—Insomnia—Perindopril—coronary artery disease	0.00121	0.00201	CcSEcCtD
Mepenzolate—Asthenia—Eplerenone—coronary artery disease	0.00121	0.00201	CcSEcCtD
Mepenzolate—Urticaria—Niacin—coronary artery disease	0.0012	0.00199	CcSEcCtD
Mepenzolate—Nausea—Acetylsalicylic acid—coronary artery disease	0.0012	0.00198	CcSEcCtD
Mepenzolate—Dizziness—Fenofibrate—coronary artery disease	0.00119	0.00197	CcSEcCtD
Mepenzolate—Somnolence—Perindopril—coronary artery disease	0.00119	0.00197	CcSEcCtD
Mepenzolate—Feeling abnormal—Trandolapril—coronary artery disease	0.00119	0.00197	CcSEcCtD
Mepenzolate—Feeling abnormal—Enalapril—coronary artery disease	0.00118	0.00196	CcSEcCtD
Mepenzolate—Urticaria—Pravastatin—coronary artery disease	0.00118	0.00196	CcSEcCtD
Mepenzolate—Asthenia—Simvastatin—coronary artery disease	0.00118	0.00195	CcSEcCtD
Mepenzolate—Constipation—Captopril—coronary artery disease	0.00118	0.00195	CcSEcCtD
Mepenzolate—Tension—Lisinopril—coronary artery disease	0.00117	0.00195	CcSEcCtD
Mepenzolate—Dizziness—Clopidogrel—coronary artery disease	0.00117	0.00194	CcSEcCtD
Mepenzolate—Feeling abnormal—Telmisartan—coronary artery disease	0.00117	0.00194	CcSEcCtD
Mepenzolate—Palpitations—Ramipril—coronary artery disease	0.00116	0.00193	CcSEcCtD
Mepenzolate—Dizziness—Lovastatin—coronary artery disease	0.00116	0.00193	CcSEcCtD
Mepenzolate—Nervousness—Lisinopril—coronary artery disease	0.00116	0.00193	CcSEcCtD
Mepenzolate—Somnolence—Furosemide—coronary artery disease	0.00116	0.00192	CcSEcCtD
Mepenzolate—Urticaria—Trandolapril—coronary artery disease	0.00115	0.0019	CcSEcCtD
Mepenzolate—Constipation—Perindopril—coronary artery disease	0.00114	0.0019	CcSEcCtD
Mepenzolate—Vomiting—Fenofibrate—coronary artery disease	0.00114	0.0019	CcSEcCtD
Mepenzolate—Hypersensitivity—Valsartan—coronary artery disease	0.00114	0.0019	CcSEcCtD
Mepenzolate—Urticaria—Enalapril—coronary artery disease	0.00114	0.00189	CcSEcCtD
Mepenzolate—Dizziness—Ezetimibe—coronary artery disease	0.00114	0.00189	CcSEcCtD
Mepenzolate—Palpitations—Timolol—coronary artery disease	0.00114	0.00189	CcSEcCtD
Mepenzolate—Feeling abnormal—Captopril—coronary artery disease	0.00114	0.00188	CcSEcCtD
Mepenzolate—Insomnia—Losartan—coronary artery disease	0.00113	0.00188	CcSEcCtD
Mepenzolate—Headache—Fenofibrate—coronary artery disease	0.00113	0.00187	CcSEcCtD
Mepenzolate—Vision blurred—Lisinopril—coronary artery disease	0.00113	0.00187	CcSEcCtD
Mepenzolate—Urticaria—Telmisartan—coronary artery disease	0.00113	0.00187	CcSEcCtD
Mepenzolate—Vomiting—Clopidogrel—coronary artery disease	0.00112	0.00186	CcSEcCtD
Mepenzolate—Vomiting—Lovastatin—coronary artery disease	0.00112	0.00185	CcSEcCtD
Mepenzolate—Somnolence—Losartan—coronary artery disease	0.00112	0.00185	CcSEcCtD
Mepenzolate—Dizziness—Eplerenone—coronary artery disease	0.00111	0.00185	CcSEcCtD
Mepenzolate—Asthenia—Valsartan—coronary artery disease	0.00111	0.00185	CcSEcCtD
Mepenzolate—Constipation—Furosemide—coronary artery disease	0.00111	0.00184	CcSEcCtD
Mepenzolate—Hypersensitivity—Niacin—coronary artery disease	0.00111	0.00184	CcSEcCtD
Mepenzolate—Asthenia—Olmesartan—coronary artery disease	0.00111	0.00184	CcSEcCtD
Mepenzolate—Headache—Clopidogrel—coronary artery disease	0.00111	0.00184	CcSEcCtD
Mepenzolate—Feeling abnormal—Perindopril—coronary artery disease	0.0011	0.00183	CcSEcCtD
Mepenzolate—Headache—Lovastatin—coronary artery disease	0.0011	0.00182	CcSEcCtD
Mepenzolate—Dry mouth—Ramipril—coronary artery disease	0.0011	0.00182	CcSEcCtD
Mepenzolate—Vomiting—Ezetimibe—coronary artery disease	0.0011	0.00182	CcSEcCtD
Mepenzolate—Hypersensitivity—Pravastatin—coronary artery disease	0.00109	0.00181	CcSEcCtD
Mepenzolate—Dizziness—Simvastatin—coronary artery disease	0.00109	0.0018	CcSEcCtD
Mepenzolate—Confusional state—Ramipril—coronary artery disease	0.00108	0.0018	CcSEcCtD
Mepenzolate—Asthenia—Niacin—coronary artery disease	0.00108	0.00179	CcSEcCtD
Mepenzolate—Headache—Ezetimibe—coronary artery disease	0.00108	0.00179	CcSEcCtD
Mepenzolate—Anaphylactic shock—Ramipril—coronary artery disease	0.00108	0.00178	CcSEcCtD
Mepenzolate—Dry mouth—Timolol—coronary artery disease	0.00107	0.00178	CcSEcCtD
Mepenzolate—Constipation—Losartan—coronary artery disease	0.00107	0.00178	CcSEcCtD
Mepenzolate—Vomiting—Eplerenone—coronary artery disease	0.00107	0.00178	CcSEcCtD
Mepenzolate—Feeling abnormal—Furosemide—coronary artery disease	0.00107	0.00178	CcSEcCtD
Mepenzolate—Nausea—Fenofibrate—coronary artery disease	0.00107	0.00177	CcSEcCtD
Mepenzolate—Asthenia—Pravastatin—coronary artery disease	0.00107	0.00177	CcSEcCtD
Mepenzolate—Urticaria—Perindopril—coronary artery disease	0.00106	0.00176	CcSEcCtD
Mepenzolate—Hypersensitivity—Trandolapril—coronary artery disease	0.00106	0.00176	CcSEcCtD
Mepenzolate—Confusional state—Timolol—coronary artery disease	0.00106	0.00176	CcSEcCtD
Mepenzolate—Hypersensitivity—Enalapril—coronary artery disease	0.00106	0.00176	CcSEcCtD
Mepenzolate—Palpitations—Lisinopril—coronary artery disease	0.00106	0.00175	CcSEcCtD
Mepenzolate—Headache—Eplerenone—coronary artery disease	0.00106	0.00175	CcSEcCtD
Mepenzolate—Anaphylactic shock—Timolol—coronary artery disease	0.00105	0.00174	CcSEcCtD
Mepenzolate—Nausea—Clopidogrel—coronary artery disease	0.00105	0.00174	CcSEcCtD
Mepenzolate—Tachycardia—Ramipril—coronary artery disease	0.00105	0.00174	CcSEcCtD
Mepenzolate—Vomiting—Simvastatin—coronary artery disease	0.00104	0.00173	CcSEcCtD
Mepenzolate—Hypersensitivity—Telmisartan—coronary artery disease	0.00104	0.00173	CcSEcCtD
Mepenzolate—Nausea—Lovastatin—coronary artery disease	0.00104	0.00173	CcSEcCtD
Mepenzolate—Asthenia—Trandolapril—coronary artery disease	0.00103	0.00172	CcSEcCtD
Mepenzolate—Feeling abnormal—Losartan—coronary artery disease	0.00103	0.00171	CcSEcCtD
Mepenzolate—Urticaria—Furosemide—coronary artery disease	0.00103	0.00171	CcSEcCtD
Mepenzolate—Asthenia—Enalapril—coronary artery disease	0.00103	0.00171	CcSEcCtD
Mepenzolate—Headache—Simvastatin—coronary artery disease	0.00103	0.00171	CcSEcCtD
Mepenzolate—Dizziness—Valsartan—coronary artery disease	0.00103	0.0017	CcSEcCtD
Mepenzolate—Nausea—Ezetimibe—coronary artery disease	0.00102	0.0017	CcSEcCtD
Mepenzolate—Dizziness—Olmesartan—coronary artery disease	0.00102	0.00169	CcSEcCtD
Mepenzolate—Asthenia—Telmisartan—coronary artery disease	0.00102	0.00169	CcSEcCtD
Mepenzolate—Nausea—Eplerenone—coronary artery disease	0.001	0.00166	CcSEcCtD
Mepenzolate—Dizziness—Niacin—coronary artery disease	0.000997	0.00165	CcSEcCtD
Mepenzolate—Urticaria—Losartan—coronary artery disease	0.000997	0.00165	CcSEcCtD
Mepenzolate—Dry mouth—Lisinopril—coronary artery disease	0.000995	0.00165	CcSEcCtD
Mepenzolate—Asthenia—Captopril—coronary artery disease	0.000988	0.00164	CcSEcCtD
Mepenzolate—Vomiting—Valsartan—coronary artery disease	0.000986	0.00164	CcSEcCtD
Mepenzolate—Confusional state—Lisinopril—coronary artery disease	0.000984	0.00163	CcSEcCtD
Mepenzolate—Dizziness—Pravastatin—coronary artery disease	0.000982	0.00163	CcSEcCtD
Mepenzolate—Vomiting—Olmesartan—coronary artery disease	0.000982	0.00163	CcSEcCtD
Mepenzolate—Nausea—Simvastatin—coronary artery disease	0.000976	0.00162	CcSEcCtD
Mepenzolate—Anaphylactic shock—Lisinopril—coronary artery disease	0.000976	0.00162	CcSEcCtD
Mepenzolate—Insomnia—Ramipril—coronary artery disease	0.000973	0.00161	CcSEcCtD
Mepenzolate—Headache—Valsartan—coronary artery disease	0.000972	0.00161	CcSEcCtD
Mepenzolate—Headache—Olmesartan—coronary artery disease	0.000967	0.0016	CcSEcCtD
Mepenzolate—Asthenia—Perindopril—coronary artery disease	0.00096	0.00159	CcSEcCtD
Mepenzolate—Vomiting—Niacin—coronary artery disease	0.000959	0.00159	CcSEcCtD
Mepenzolate—Hypersensitivity—Furosemide—coronary artery disease	0.000958	0.00159	CcSEcCtD
Mepenzolate—Somnolence—Ramipril—coronary artery disease	0.000956	0.00159	CcSEcCtD
Mepenzolate—Dizziness—Trandolapril—coronary artery disease	0.000954	0.00158	CcSEcCtD
Mepenzolate—Tachycardia—Lisinopril—coronary artery disease	0.000952	0.00158	CcSEcCtD
Mepenzolate—Insomnia—Timolol—coronary artery disease	0.000951	0.00158	CcSEcCtD
Mepenzolate—Dizziness—Enalapril—coronary artery disease	0.00095	0.00158	CcSEcCtD
Mepenzolate—Headache—Niacin—coronary artery disease	0.000945	0.00157	CcSEcCtD
Mepenzolate—Vomiting—Pravastatin—coronary artery disease	0.000944	0.00157	CcSEcCtD
Mepenzolate—Dizziness—Telmisartan—coronary artery disease	0.000937	0.00155	CcSEcCtD
Mepenzolate—Somnolence—Timolol—coronary artery disease	0.000935	0.00155	CcSEcCtD
Mepenzolate—Asthenia—Furosemide—coronary artery disease	0.000933	0.00155	CcSEcCtD
Mepenzolate—Headache—Pravastatin—coronary artery disease	0.00093	0.00154	CcSEcCtD
Mepenzolate—Hypersensitivity—Losartan—coronary artery disease	0.000924	0.00153	CcSEcCtD
Mepenzolate—Nausea—Valsartan—coronary artery disease	0.000921	0.00153	CcSEcCtD
Mepenzolate—Constipation—Ramipril—coronary artery disease	0.00092	0.00153	CcSEcCtD
Mepenzolate—Nausea—Olmesartan—coronary artery disease	0.000917	0.00152	CcSEcCtD
Mepenzolate—Vomiting—Trandolapril—coronary artery disease	0.000917	0.00152	CcSEcCtD
Mepenzolate—Vomiting—Enalapril—coronary artery disease	0.000913	0.00151	CcSEcCtD
Mepenzolate—Dizziness—Captopril—coronary artery disease	0.000911	0.00151	CcSEcCtD
Mepenzolate—Headache—Trandolapril—coronary artery disease	0.000903	0.0015	CcSEcCtD
Mepenzolate—Vomiting—Telmisartan—coronary artery disease	0.000901	0.00149	CcSEcCtD
Mepenzolate—Asthenia—Losartan—coronary artery disease	0.0009	0.00149	CcSEcCtD
Mepenzolate—Headache—Enalapril—coronary artery disease	0.0009	0.00149	CcSEcCtD
Mepenzolate—Nausea—Niacin—coronary artery disease	0.000896	0.00149	CcSEcCtD
Mepenzolate—Headache—Telmisartan—coronary artery disease	0.000887	0.00147	CcSEcCtD
Mepenzolate—Feeling abnormal—Ramipril—coronary artery disease	0.000886	0.00147	CcSEcCtD
Mepenzolate—Dizziness—Perindopril—coronary artery disease	0.000884	0.00147	CcSEcCtD
Mepenzolate—Insomnia—Lisinopril—coronary artery disease	0.000882	0.00146	CcSEcCtD
Mepenzolate—Nausea—Pravastatin—coronary artery disease	0.000882	0.00146	CcSEcCtD
Mepenzolate—Vomiting—Captopril—coronary artery disease	0.000876	0.00145	CcSEcCtD
Mepenzolate—Methadone—OPRD1—coronary artery disease	0.000873	0.0511	CrCbGaD
Mepenzolate—Somnolence—Lisinopril—coronary artery disease	0.000867	0.00144	CcSEcCtD
Mepenzolate—Feeling abnormal—Timolol—coronary artery disease	0.000867	0.00144	CcSEcCtD
Mepenzolate—Headache—Captopril—coronary artery disease	0.000863	0.00143	CcSEcCtD
Mepenzolate—Dizziness—Furosemide—coronary artery disease	0.00086	0.00143	CcSEcCtD
Mepenzolate—Nausea—Trandolapril—coronary artery disease	0.000857	0.00142	CcSEcCtD
Mepenzolate—Urticaria—Ramipril—coronary artery disease	0.000855	0.00142	CcSEcCtD
Mepenzolate—Nausea—Enalapril—coronary artery disease	0.000853	0.00142	CcSEcCtD
Mepenzolate—Vomiting—Perindopril—coronary artery disease	0.00085	0.00141	CcSEcCtD
Mepenzolate—Nausea—Telmisartan—coronary artery disease	0.000841	0.0014	CcSEcCtD
Mepenzolate—Headache—Perindopril—coronary artery disease	0.000838	0.00139	CcSEcCtD
Mepenzolate—Urticaria—Timolol—coronary artery disease	0.000835	0.00139	CcSEcCtD
Mepenzolate—Constipation—Lisinopril—coronary artery disease	0.000834	0.00138	CcSEcCtD
Mepenzolate—Dizziness—Losartan—coronary artery disease	0.00083	0.00138	CcSEcCtD
Mepenzolate—Vomiting—Furosemide—coronary artery disease	0.000827	0.00137	CcSEcCtD
Mepenzolate—Nausea—Captopril—coronary artery disease	0.000818	0.00136	CcSEcCtD
Mepenzolate—Headache—Furosemide—coronary artery disease	0.000815	0.00135	CcSEcCtD
Mepenzolate—Feeling abnormal—Lisinopril—coronary artery disease	0.000804	0.00133	CcSEcCtD
Mepenzolate—Vomiting—Losartan—coronary artery disease	0.000798	0.00132	CcSEcCtD
Mepenzolate—Nausea—Perindopril—coronary artery disease	0.000794	0.00132	CcSEcCtD
Mepenzolate—Hypersensitivity—Ramipril—coronary artery disease	0.000793	0.00131	CcSEcCtD
Mepenzolate—Headache—Losartan—coronary artery disease	0.000786	0.0013	CcSEcCtD
Mepenzolate—Urticaria—Lisinopril—coronary artery disease	0.000775	0.00129	CcSEcCtD
Mepenzolate—Hypersensitivity—Timolol—coronary artery disease	0.000775	0.00129	CcSEcCtD
Mepenzolate—Nausea—Furosemide—coronary artery disease	0.000772	0.00128	CcSEcCtD
Mepenzolate—Asthenia—Ramipril—coronary artery disease	0.000772	0.00128	CcSEcCtD
Mepenzolate—Asthenia—Timolol—coronary artery disease	0.000755	0.00125	CcSEcCtD
Mepenzolate—Nausea—Losartan—coronary artery disease	0.000745	0.00124	CcSEcCtD
Mepenzolate—Hypersensitivity—Lisinopril—coronary artery disease	0.000719	0.00119	CcSEcCtD
Mepenzolate—Dizziness—Ramipril—coronary artery disease	0.000711	0.00118	CcSEcCtD
Mepenzolate—Benzatropine—CYP2C19—coronary artery disease	0.000703	0.0411	CrCbGaD
Mepenzolate—Asthenia—Lisinopril—coronary artery disease	0.0007	0.00116	CcSEcCtD
Mepenzolate—Dizziness—Timolol—coronary artery disease	0.000695	0.00115	CcSEcCtD
Mepenzolate—Vomiting—Ramipril—coronary artery disease	0.000684	0.00113	CcSEcCtD
Mepenzolate—Headache—Ramipril—coronary artery disease	0.000674	0.00112	CcSEcCtD
Mepenzolate—Vomiting—Timolol—coronary artery disease	0.000669	0.00111	CcSEcCtD
Mepenzolate—Headache—Timolol—coronary artery disease	0.000659	0.00109	CcSEcCtD
Mepenzolate—Dizziness—Lisinopril—coronary artery disease	0.000645	0.00107	CcSEcCtD
Mepenzolate—Nausea—Ramipril—coronary artery disease	0.000639	0.00106	CcSEcCtD
Mepenzolate—Nausea—Timolol—coronary artery disease	0.000625	0.00104	CcSEcCtD
Mepenzolate—Vomiting—Lisinopril—coronary artery disease	0.00062	0.00103	CcSEcCtD
Mepenzolate—Headache—Lisinopril—coronary artery disease	0.000611	0.00101	CcSEcCtD
Mepenzolate—Nausea—Lisinopril—coronary artery disease	0.000579	0.000961	CcSEcCtD
Mepenzolate—Methadone—CYP2C19—coronary artery disease	0.000349	0.0204	CrCbGaD
Mepenzolate—CHRM3—Signaling Pathways—JUNB—coronary artery disease	5.07e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	5.06e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	5.05e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARGC1A—coronary artery disease	5.04e-05	0.000133	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—coronary artery disease	5.02e-05	0.000132	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JUNB—coronary artery disease	5.02e-05	0.000132	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	5e-05	0.000132	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR7—coronary artery disease	4.96e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CAT—coronary artery disease	4.95e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR7—coronary artery disease	4.94e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR7—coronary artery disease	4.9e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOB—coronary artery disease	4.81e-05	0.000127	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	4.73e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KNG1—coronary artery disease	4.71e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	4.71e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KNG1—coronary artery disease	4.7e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—POMC—coronary artery disease	4.7e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	4.7e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	4.68e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—POMC—coronary artery disease	4.68e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	4.68e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTM1—coronary artery disease	4.68e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	4.67e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	4.66e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KNG1—coronary artery disease	4.65e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	4.64e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—POMC—coronary artery disease	4.64e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	4.62e-05	0.000122	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	4.59e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—LPL—coronary artery disease	4.59e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	4.58e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	4.58e-05	0.000121	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	4.58e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	4.57e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLG—coronary artery disease	4.56e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	4.56e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLG—coronary artery disease	4.55e-05	0.00012	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	4.54e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	4.52e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	4.52e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLG—coronary artery disease	4.51e-05	0.000119	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—coronary artery disease	4.48e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	4.44e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	4.43e-05	0.000117	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	4.39e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	4.39e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	4.38e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	4.38e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	4.37e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	4.37e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—S100B—coronary artery disease	4.36e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD36—coronary artery disease	4.36e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	4.36e-05	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—S100B—coronary artery disease	4.35e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	4.33e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	4.33e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	4.32e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	4.32e-05	0.000114	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPP2CA—coronary artery disease	4.31e-05	0.000113	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—S100B—coronary artery disease	4.31e-05	0.000113	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	4.31e-05	0.000113	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	4.27e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KITLG—coronary artery disease	4.27e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	4.27e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KITLG—coronary artery disease	4.26e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	4.26e-05	0.000112	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KITLG—coronary artery disease	4.22e-05	0.000111	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	4.22e-05	0.000111	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	4.17e-05	0.00011	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP3—coronary artery disease	4.17e-05	0.00011	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP3—coronary artery disease	4.16e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	4.16e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MTHFR—coronary artery disease	4.14e-05	0.000109	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	4.12e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP3—coronary artery disease	4.12e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOB—coronary artery disease	4.03e-05	0.000106	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOB—coronary artery disease	4.02e-05	0.000106	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	4e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	3.99e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOB—coronary artery disease	3.98e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	3.98e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EDN1—coronary artery disease	3.97e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	3.97e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EDN1—coronary artery disease	3.96e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	3.95e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL5—coronary artery disease	3.94e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	3.93e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGT—coronary artery disease	3.93e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL5—coronary artery disease	3.93e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EDN1—coronary artery disease	3.92e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL5—coronary artery disease	3.89e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGF1—coronary artery disease	3.88e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CSF2—coronary artery disease	3.88e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGF1—coronary artery disease	3.87e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CSF2—coronary artery disease	3.87e-05	0.000102	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LPL—coronary artery disease	3.85e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—coronary artery disease	3.85e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LPL—coronary artery disease	3.84e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CSF2—coronary artery disease	3.83e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGF1—coronary artery disease	3.83e-05	0.000101	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	3.82e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	3.82e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	3.81e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	3.81e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOA1—coronary artery disease	3.81e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LPL—coronary artery disease	3.8e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	3.77e-05	9.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	3.77e-05	9.92e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	3.72e-05	9.79e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	3.71e-05	9.76e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	3.67e-05	9.66e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	3.63e-05	9.56e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	3.62e-05	9.53e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	3.61e-05	9.51e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	3.6e-05	9.48e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	3.59e-05	9.44e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	3.57e-05	9.39e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	3.55e-05	9.34e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	3.54e-05	9.31e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	3.5e-05	9.22e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	3.47e-05	9.14e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—C3—coronary artery disease	3.47e-05	9.13e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	3.46e-05	9.11e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—C3—coronary artery disease	3.46e-05	9.1e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	3.43e-05	9.02e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—C3—coronary artery disease	3.42e-05	9.01e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARG—coronary artery disease	3.35e-05	8.82e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	3.31e-05	8.7e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—POMC—coronary artery disease	3.31e-05	8.7e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	3.3e-05	8.68e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGT—coronary artery disease	3.3e-05	8.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGT—coronary artery disease	3.29e-05	8.64e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	3.27e-05	8.59e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGT—coronary artery disease	3.25e-05	8.56e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—LEP—coronary artery disease	3.23e-05	8.5e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—coronary artery disease	3.23e-05	8.5e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—LEP—coronary artery disease	3.22e-05	8.47e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—coronary artery disease	3.22e-05	8.47e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOA1—coronary artery disease	3.19e-05	8.4e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—coronary artery disease	3.19e-05	8.39e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—LEP—coronary artery disease	3.19e-05	8.39e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOA1—coronary artery disease	3.18e-05	8.37e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KDR—coronary artery disease	3.16e-05	8.32e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KDR—coronary artery disease	3.15e-05	8.3e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOA1—coronary artery disease	3.15e-05	8.29e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	3.14e-05	8.27e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	3.13e-05	8.24e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KDR—coronary artery disease	3.12e-05	8.22e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	3.1e-05	8.16e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ESR1—coronary artery disease	3.08e-05	8.11e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ESR1—coronary artery disease	3.07e-05	8.09e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—F2—coronary artery disease	3.05e-05	8.01e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FN1—coronary artery disease	3.05e-05	8.01e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ESR1—coronary artery disease	3.04e-05	8.01e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—F2—coronary artery disease	3.04e-05	7.99e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FN1—coronary artery disease	3.04e-05	7.99e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	3.03e-05	7.98e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	3.02e-05	7.96e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALB—coronary artery disease	3.01e-05	7.93e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	3.01e-05	7.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—F2—coronary artery disease	3.01e-05	7.91e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FN1—coronary artery disease	3.01e-05	7.91e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	3e-05	7.89e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.99e-05	7.88e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.97e-05	7.82e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.91e-05	7.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KIT—coronary artery disease	2.91e-05	7.64e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NOS3—coronary artery disease	2.88e-05	7.59e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.88e-05	7.57e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.8e-05	7.36e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	2.79e-05	7.33e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.77e-05	7.3e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.77e-05	7.3e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—POMC—coronary artery disease	2.77e-05	7.28e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CREB1—coronary artery disease	2.77e-05	7.28e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.76e-05	7.26e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—POMC—coronary artery disease	2.74e-05	7.21e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2.74e-05	7.21e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL2—coronary artery disease	2.71e-05	7.14e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.71e-05	7.12e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL2—coronary artery disease	2.71e-05	7.12e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6R—coronary artery disease	2.7e-05	7.1e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.68e-05	7.05e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.67e-05	7.03e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.67e-05	7.02e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF1—coronary artery disease	2.66e-05	7e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.66e-05	6.99e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	2.65e-05	6.97e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—coronary artery disease	2.64e-05	6.94e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.63e-05	6.93e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.62e-05	6.9e-05	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.54e-05	6.68e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.53e-05	6.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	2.53e-05	6.66e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	2.53e-05	6.65e-05	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2.5e-05	6.59e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	2.5e-05	6.58e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.45e-05	6.45e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGF2—coronary artery disease	2.45e-05	6.43e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGF2—coronary artery disease	2.42e-05	6.37e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.42e-05	6.37e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOS3—coronary artery disease	2.41e-05	6.35e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOS3—coronary artery disease	2.39e-05	6.28e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.35e-05	6.19e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JAK2—coronary artery disease	2.34e-05	6.17e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JAK2—coronary artery disease	2.32e-05	6.11e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.3e-05	6.06e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	2.3e-05	6.04e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	2.27e-05	5.99e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.15e-05	5.65e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	2.14e-05	5.63e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.12e-05	5.57e-05	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.07e-05	5.45e-05	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.07e-05	5.44e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.05e-05	5.4e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CASP3—coronary artery disease	2.05e-05	5.39e-05	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.05e-05	5.38e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.04e-05	5.37e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6—coronary artery disease	2.03e-05	5.35e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.03e-05	5.33e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.01e-05	5.3e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2e-05	5.26e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.99e-05	5.24e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.97e-05	5.19e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.94e-05	5.11e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.93e-05	5.09e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.92e-05	5.04e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.88e-05	4.95e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.88e-05	4.94e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.86e-05	4.89e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.74e-05	4.59e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.74e-05	4.57e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.72e-05	4.53e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CA—coronary artery disease	1.62e-05	4.27e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.6e-05	4.21e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	1.59e-05	4.2e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.58e-05	4.16e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.57e-05	4.13e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	1.56e-05	4.11e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.55e-05	4.07e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.36e-05	3.58e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.36e-05	3.57e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.34e-05	3.54e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKT1—coronary artery disease	1.33e-05	3.49e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.21e-05	3.17e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.2e-05	3.16e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.19e-05	3.13e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.11e-05	2.93e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.11e-05	2.92e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.1e-05	2.89e-05	CbGpPWpGaD
